Predicting Operative Mortality After Surgery for Ischemic Cardiomyopathy

Annals of Thoracic Surgery

Volumn 83, Issue 6, 2007, Pages 2029-2035

  Fedoruk, Lynn M ^a   Tribble, Curtis G ^a   Kern, John A ^a   Peeler, Benjamin B ^a   Kron, Irving L ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AORTA BALLOON; ARTICLE; CARDIOMYOPATHY; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DATA BASE; DIABETES MELLITUS; EMERGENCY SURGERY; FEMALE; HEART EJECTION FRACTION; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE REMODELING; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MITRAL VALVE REGURGITATION; MITRAL VALVE REPLACEMENT; OUTCOME ASSESSMENT; PATIENT IDENTIFICATION; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; SURGICAL MORTALITY; SURGICAL RISK; SURGICAL TECHNIQUE; THORAX SURGERY; TREATMENT PLANNING;

ADULT; AGED; AGED, 80 AND OVER; CARDIAC SURGICAL PROCEDURES; CARDIOMYOPATHIES; FEMALE; FORECASTING; HEART FAILURE, CONGESTIVE; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 34249059655     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2007.01.035     Document Type: Article

References (30)

1. American Heart Association. 2002 Heart and stroke statistical update (2001), American Heart Association, Dallas, TX
2. Carson P.E. Beta blocker treatment in heart failure. Prog Cardiovasc Dis 41 (1999) 301-321
3. Hunt S.A., American College of Cardiology, and American Heart Association Task Force on Practice Guidelines. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to update the 2001 guidelines for the evaluation and management of heart failure). J Am Coll Cardiol 46 (2005) 1-82
4. Felker G.M., Shaw L.K., and O'Connor C.M. A standardized definition of ischemic cardiomyopathy for use in clinical research. J Am Coll Cardiol 39 (2002) 210-218
5. Gheorghiade M., and Bonow R.O. Chronic heart failure in the United States. A manifestation of coronary artery disease. Circulation 97 (1998) 282-289
6. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 316 (1987) 1429-1435
7. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 336 (1997) 525-533
8. Packer M., Bristow M.R., Cohn J.N., et al., U.S. Carvedilol Heart Failure Study Group. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 334 (1996) 1349-1355
9. Levy D., Kenchaiah S., Larson M.G., et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 347 (2002) 1397-1402
10. Buckberg G.D. Congestive heart failure: treat the disease, not the symptom-return to normalcy. J Thorac Cardiovasc Surg 121 (2001) 628-637
11. Blondheim D.S., Jacobs L.E., Kotler M.N., Costacurta G.A., and Parry W.R. Dilated cardiomyopathy with mitral regurgitation: decreased survival despite a low frequency of left ventricular thrombus. Am Heart J 122 (1991) 763-771
12. Hickey M.S., Smith L.R., and Muhlbaier L.H. Current prognosis of ischemic mitral regurgitation: implications for future management. Circulation 78 (1988) 51-59
13. Allman K.C., Shaw L.J., Hachamovitch R., and Udelson J.E. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 39 (2002) 1151-1158
14. Mehra M.R., Kobashigawa J., Starling R., et al. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates-2006. J Heart Lung Transplant 25 (2006) 1024-1042
15. Athanasuleas C.L., Stanley Jr. A.W., Buckberg G.D., Dor V., Di Donato M., and Blackstone E.H. Surgical anterior ventricular endocardial restoration (SAVER) in the dilated remodeled ventricle after anterior myocardial infarction. J Am Coll Cardiol 37 (2001) 1199-1209
16. Mickleborough L.L., Carson S., and Ivanov J. Repair of dyskinetic or akinetic left ventricular aneurysm: results obtained with a modified linear closure. J Thorac Cardiovasc Surg 121 (2001) 675-682
17. Bart B.A., Shaw L.K., McCants C.B., et al. Clinical determinants of mortality in patients with angiographically diagnosed ischemic of nonischemic cardiomyopathy. J Am Coll Cardiol 30 (1997) 1002-1008
18. Adams K.F., Dunlap S.H., Sueta C.A., et al. Relation between gender, etiology and survival in patients with symptomatic heart failure. J Am Coll Cardiol 28 (1996) 1781-1788
19. Bolling S.F., Smolens I.A., and Pagani F.D. Surgical alternatives for heart failure. J Heart Lung Transplant 20 (2001) 729-733
20. Aziz T., Burgess M., Rahman A.N., Campbell C.S., and Yonan N. Cardiac transplantation for cardiomyopathy and ischemic disease: differences in outcome up to 10 years. J Heart Lung Transplant 20 (2001) 525-533
21. Migrino R.Q., Young J.B., Ellis S.G., et al., The Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I Angiographic Investigators. End-systolic volume index at 90 to 180 minutes into reperfusion therapy for acute myocardial infarction is a strong predictor of early and late mortality. Circulation 96 (1997) 116-121
22. White H.D., Norris R.M., Brown M.A., Brandt P.W., Whitlock R.M., and Wild C.J. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 76 (1987) 44-51
23. Gillinov A.M., Wierup P.N., Blackstone E.H., et al. Is repair preferable to replacement for ischemic mitral regurgitation?. J Thorac Cardiovasc Surg 122 (2001) 1125-1141
24. Grossi E.A., Goldberg J.D., LaPietra A., et al. Ischemic mitral valve reconstruction and replacement: comparison of long-term survival and complications. J Thorac Cardiovasc Surg 122 (2001) 1107-1124
25. Adams J.D., Fedoruk L.M., Tache-Leon C.A., et al. Does preoperative ejection fraction predict operative mortality with left ventricular restoration?. Ann Thorac Surg 82 (2006) 1715-1720
26. Hausmann H., Topp H., Siniawski H., Holz S., and Hetzer R. Decision making in end-stage coronary artery disease: revascularization or heart transplantation. Ann Thorac Surg 64 (1997) 1296-1302
27. Baker D.W., Jones R., Hodges J., Massie B.M., Konstam M.A., and Rose E.A. Management of heart failure, III: the role of revascularization in the treatment of patients with moderate or severe left ventricular systolic dysfunction. JAMA 272 (1994) 1528-1534
28. Haas F., Augustin N., Holper K., et al. Time course and extent of improvement of dysfunctioning myocardium in patients with coronary artery disease and severely depressed left ventricular function after revascularization: correlation with positron emission tomographic findings. J Am College Cardiol 36 (2000) 1927-1934
29. Cooper W.A., O'Brien S.M., Thourani V.H., et al. Impact of renal dysfunction on outcomes of coronary artery bypass surgery. Results from The Society of Thoracic Surgeons National Adult Cardiac Database. Circulation 113 (2006) 1063-1070
30. Hochman J.S., Sleeper L.A., Webb J.G., et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med 341 (1999) 625-634